Breaking News Instant updates and real-time market news.

SGH

Smart Global

$22.50

1.05 (4.90%)

, TSN

Tyson Foods

$65.45

-0.73 (-1.10%)

17:40
09/28/17
09/28
17:40
09/28/17
17:40

On The Fly: After Hours Movers

UP AFTER EARNINGS: Smart Global (SGH), up 6.2%... Tyson Foods (TSN), up 5.4%... KB Home (KBH), up 1.1%. ALSO HIGHER: Aehr Test Systems (AEHR), up 16.5% after it received follow-on orders for its FOX-XP Test and Burin-in Solution... Aptevo Therapeutics (APVO), up 13% after it amended its loan agreement with MidCap Financial... A10 Networks (ATEN), up 12.8% after it raised its third quarter revenue guidance... Zynerba (ZYNE), up 4.9% after the stock was upgraded to Overweight from Neutral at Piper Jaffray... Marinus Pharmaceuticals (MRNS), up 3.6% after Bain Capital Life Sciences Fund reported a 15.8% passive stake in the company. LOWER: Western Refining Logistics (WNRL), down 0.8% after its board set a September 28 record date for determining holders of WNRL common units entitled to execute and deliver written consents with respect to its proposed acquisition by Andeavor Logistics (ANDX).

SGH

Smart Global

$22.50

1.05 (4.90%)

TSN

Tyson Foods

$65.45

-0.73 (-1.10%)

KBH

KB Home

$22.22

0.61 (2.82%)

AEHR

Aehr Test Systems

$3.52

0.35 (11.04%)

ATEN

A10 Networks

$6.65

-0.06 (-0.89%)

APVO

Aptevo Therapeutics

$2.16

-0.05 (-2.26%)

MRNS

Marinus Pharmaceuticals

$5.59

-0.28 (-4.77%)

ZYNE

Zynerba

$9.44

3.25 (52.50%)

WNRL

Western Refining Logistics

$25.60

0.45 (1.79%)

ANDX

Andeavor Logistics

$49.04

0.7 (1.45%)

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 10

    Oct

  • 16

    Nov

SGH Smart Global
$22.50

1.05 (4.90%)

06/19/17
06/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Qualcomm (QCOM) reinstated with a Hold at Deutsche Bank. 2. WideOpenWest (WOW) was initiated with an Outperform at Macquarie, RBC Capital, Credit Suisse, and Evercore ISI, a Strong Buy at Raymond James, as well as a Buy at SunTrust and UBS. 3. Appian (APPN) was initiated with an Outperform at Cowen, an Equal Weight at Morgan Stanley and Barclays, a Sector Weight at Pacific Crest, a Hold at Canaccord, and a Neutral at Goldman Sachs. 4. Smart Global (SGH) was initiated with an Overweight at Barclays, a Strong Buy at Needham, and a Buy at Roth Capital, Stifel, Jefferies, and Deutsche Bank. 5. Credit Suisse (CS) resumed with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/17
ROTH
06/19/17
INITIATION
Target $24
ROTH
Buy
Smart Global initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Smart Global Holdings with a Buy rating and a $24 price target, saying he is encouraged by the company's growth and share expansion opportunity as well as its differentiated specialty memory offering.
06/19/17
STFL
06/19/17
INITIATION
STFL
Buy
Smart Global initiated with a Buy at Stifel
Stifel analyst Kevin Cassidy started coverage of Smart Global with a $27 price target and a Buy rating. The analyst says that the company's Specialty Memory unit is "poised to benefit from the increased importance of memory in the datacenter architecture." He also expects the company to benefit from increased smartphone adoption in Brazil and higher content memory requirements there.
06/19/17
NEED
06/19/17
INITIATION
Target $20
NEED
Strong Buy
Smart Global initiated with a Strong Buy at Needham
Needham analyst Rajvindra Gill initiated Smart Global with a Strong Buy and a $20 price target.
TSN Tyson Foods
$65.45

-0.73 (-1.10%)

07/19/17
07/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyson Foods (TSN) reinstated with a Neutral at Credit Suisse. 2. Bob Evans (BOBE) initiated with a Buy at Berenberg. 3. Quanex (NX) coverage assumed with an Outperform at Wedbush. 4. Agile Therapeutics (AGRX) initiated with a Buy at H.C. Wainwright. 5. Caesars (CZR) re-initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
FBCO
08/08/17
NO CHANGE
Target $70
FBCO
Neutral
Tyson Foods price target raised to $70 from $65 at Credit Suisse
Credit Suisse analyst Robert Moskow raised his price target for Tyson Foods to $70 from $65 after quarterly results. The analyst reiterates a Neutral rating on the shares.
08/08/17
GSCO
08/08/17
NO CHANGE
Target $79
GSCO
Buy
Tyson Foods trading at a discount, says Goldman Sachs
Goldman analyst Adam Samuelson said Tyson's Q3 beat and optimistic 2018 guidance were encouraging following several quarters of lackluster performance in Prepared/Chicken. The analyst has increased confidence in FY18 sustained growth and said Tyson's value-added businesses are not being appropriately reflected in current valuation. Samuelson rates Tyson a Buy with a $79 price target.
07/19/17
FBCO
07/19/17
INITIATION
Target $65
FBCO
Neutral
Tyson Foods reinstated with a Neutral at Credit Suisse
Credit Suisse analyst Robert Moskow reinstated Tyson Foods with a Neutral rating and $65 price target following its acquisition of Advance Pierre.
KBH KB Home
$22.22

0.61 (2.82%)

09/22/17
WEDB
09/22/17
NO CHANGE
Target $26
WEDB
Outperform
KB Home forward estimates may be at risk due to storms, says Wedbush
Wedbush analyst Jay McCanless says he expects KB Home to report Q3 earnings per share of 50c, above the consensus estimate of 46c. Since Hurricane Harvey struck near the end of the company's Q3 and Hurricane Irma struck after the quarter ended, most of KB's closings and orders in the affected areas occurred before the storms hit, McCanless tells investors in a pre-earnings research note. The analyst is comfortable being above consensus for Q3 but thinks his forward earnings estimates may be at risk from storm-related issues. He reiterates an Outperform rating on KB Home with a $26 price target.
07/11/17
LEHM
07/11/17
DOWNGRADE
Target $37
LEHM
Toll Brothers downgraded to Underweight from Equal Weight at Barclays
As previously reported, Barclays analyst Michael Dahl downgraded Toll Brothers (TOL) to Underweight and keeps a $37 price target for the shares. The analyst says his firm's June agency survey indicated moderating buyer traffic trends. He sees risk that near-term catalysts for builders will disappoint relative to rising expectations. As such, Dahl recommends "tactically" reducing exposure to homebuilder stocks. Along with Toll Brothers, the analyst this morning downgraded TRI Pointe (TPH), PulteGroup (PHM) and Lennar (LEN) to Equal Weight. He also upgraded CalAtlantic (CAA) to Equal Weight. Dahl reiterates Underweight ratings on KB Home (KBH), Meritage Homes (MTH) and Realogy (RLGY).
07/10/17
MZHO
07/10/17
DOWNGRADE
MZHO
Underperform
KB Home downgraded to Underperform from Neutral at Mizuho
06/27/17
BOFA
06/27/17
NO CHANGE
BOFA
US housing cycle may be inflecting higher, says BofA/Merrill
BofA/Merrill analyst John Lovallo raised single-family house starts and new home sales forecasts for 2018 and 2019 to reflect a continuation in accelerating demand over the past six months. He now expects 2018 single family starts and new homes sales of up 9% year-over-year versus 6% previously, and 2019 growth of up 8% growth year-over-year, versus 5% previously. The analyst believes demand is being supported by the return of first time home buyers, low mortgage rates, and stronger home equity positions. Lovallo raised earnings estimates across the group and reiterated D.R. Horton (DHI) and PulteGroup (PHM) as top picks.
AEHR Aehr Test Systems
$3.52

0.35 (11.04%)

10/10/16
CHLM
10/10/16
INITIATION
Target $5
CHLM
Buy
Aehr Test Systems initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Christian Scwhab initiated Aehr Test Systems (AEHR) with a Buy and a $5 price target. Scwhab is confident the company is on the cusp of both strong top and bottom line performance driven by new products and further orders from top tier semiconductor companies as evidenced by Apple (AAPL) becoming a significant customer in fiscal 2016.
04/05/17
MAXM
04/05/17
NO CHANGE
MAXM
Aehr Test Systems a 'clear beneficiary' of new iPhone features, says Maxim
Maxim analyst Nehal Chokshi said that, as with each new iPhone generation, Apple's (AAPL) implementing of new capabilities requires an increasing bill of materials cost, which will again pressure its gross margins. Noting there will be "many supply chain winners due to the added functionality," Chokshi highlighted AEHR Test Systems (AEHR) as a clear direct beneficiary since it uniquely provides a wafer-level burn-in testing tool that is used by Apple. Additionally, he identifies Intevac (IVAC) as "at least a second order beneficiary" as Apple's reported plans for wireless charging in the iPhone 8 should spur industry adoption, helping to double the company's oDLC opportunity to $1B over the next five years.
ATEN A10 Networks
$6.65

-0.06 (-0.89%)

07/14/17
07/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Market Perform from Outperform at Cowen with analyst John Blackledge lowering his 2017 and longer-term advertising revenue estimates for Snap to reflect a more competitive environment within Digital advertising. He also believes contribution from the company's new advertising monetization products like Direct Response and Self Serve are not likely to be meaningful in the near term. 2. CyberArk (CYBR) was downgraded to Equal Weight from Overweight at Stephens, to Hold from Buy at Deutsche Bank, and to Neutral from Overweight at JPMorgan. 3. At Home Group (HOME) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler citing valuation with the shares up 82% since his upgrade to Buy on November 30, 2016. 4. A10 Networks (ATEN) downgraded to Sector Weight from Overweight at KeyBanc with analyst Alex Kurtz citing "substantially" lower projected growth rates following the company's weaker than expected preliminary second quarter results. 5. Himax (HIMX) downgraded to Underperform from Perform at Oppenheimer with analyst Andrew Uerkwitz saying lowered smartphone expectations in China for 2017 will weigh on the company's near-term orders. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/31/16
DADA
10/31/16
UPGRADE
DADA
Buy
A10 Networks upgraded on valuation at DA Davidson
As noted earlier, DA Davidson upgraded A10 Networks to Buy from Neutral. Analyst Mark Kelleher upgraded the stock based on valuation. He says that the company "remains well-positioned in its core ADC and DDoS markets" despite its September quarter revenue miss. Target $10.50.
07/14/17
PIPR
07/14/17
DOWNGRADE
Target $136
PIPR
Neutral
F5 Networks downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Troy Jensen downgraded F5 Networks (FFIV) to Neutral and lowered his price target for the shares to $136 from $144. The product refresh cycle is not playing out as expected and product growth "could remain challenged," Jensen tells investors in a research note. His firm's Q2 channel survey highlighted a quarter-over-quarter downtick in demand for F5 with below plan responses outnumbering above plan responses, reversing a three quarter uptrend. Jensen says the negative preannouncement from A10 Networks (ATEN) only compounded his concerns. The analyst believes F5's previous growth assumptions and forward earnings are at risk.
07/14/17
KEYB
07/14/17
DOWNGRADE
KEYB
Sector Weight
A10 Networks downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Alex Kurtz downgraded A10 Networks to Sector Weight citing "substantially" lower projected growth rates following the company's weaker than expected preliminary Q2 results. The analyst believes regaining demand momentum could take several quarters.
APVO Aptevo Therapeutics
$2.16

-0.05 (-2.26%)

11/15/16
PIPR
11/15/16
NO CHANGE
Target $5
PIPR
Overweight
Aptevo supply issues not 'fatal setback,' says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says the IXINITY supply disruption disclosed last night by Aptevo Therapeutics is disappointing, but not a "fatal setback." IXINITY is a major revenue growth driver, but the investment case is based on cash flow from approved products being funneled into the ADAPTIR pipeline, Schimmer tells investors in a research note. He lowered his price target for Aptevo shares to $5 from $7 and keeps an Overweight rating on the stock.
MRNS Marinus Pharmaceuticals
$5.59

-0.28 (-4.77%)

09/12/17
JMPS
09/12/17
NO CHANGE
Target $11
JMPS
Outperform
Marinus price target raised to $11 from $5 at JMP Securities
JMP Securities analyst Jason Butler raised his price target on Marinus Pharmaceuticals to $11 from $5 after the company reported Phase 2 clinical trial results in patients with CDKL5 disorder that he said support the potential for the drug to have "meaningful clinical benefit." The analyst, who added that the safety profile of ganaxolone "looks clean," keeps an Outperform rating on Marinus shares.
09/30/16
JMPS
09/30/16
NO CHANGE
JMPS
Marinus Pharmaceuticals data positive, says JMP Securities
JMP Securities analyst Jason Butler says that a trial of Marinus' ganaxolone PCDH19 in female pediatric eplilepsy yielded "promising" results. The analyst says that the data is positive, while female pediatric eplilepsy is an unmet need. Butler keeps a $5 price target and Outperform rating on the shares.
ZYNE Zynerba
$9.44

3.25 (52.50%)

09/28/17
PIPR
09/28/17
UPGRADE
PIPR
Overweight
Zynerba upgraded to Overweight from Neutral at Piper Jaffray
08/21/17
ADAM
08/21/17
NO CHANGE
Target $9
ADAM
Buy
Zynerba price target lowered to $9 from $35 at Canaccord
Canaccord analyst Arinda Lee lowered her price target on Zynerba to $9 from $35 following its announcement of two failed Phase 2 cannabidiol drug trials. The analyst is still not removing epilepsy and osteoarthritis from her valuation, pending clarity on regulatory pathways. Lee maintained her Buy rating on Zynerba shares.
08/15/17
08/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Neutral from Buy at BofA/Merrill with analyst Ross Gilardi saying he is cautious into the print given recent data and expects the pace of earnings performance relative to expectations to begin to subside. 2. Zynerba (ZYNE) was downgraded to Perform from Outperform at Oppenheimer and to Hold from Buy at Jefferies. 3. Uniti Group (UNIT) downgraded to Neutral from Buy at BofA/Merrill with analyst David Barden saying Windstream's (WIN) dividend cut increases concerns about the health of the business and, combined with Uniti's increasing cost of capital, creates a negative feedback loop for the stock. 4. Farmland Partners (FPI) downgraded to Neutral from Outperform at Baird with the firm's analyst saying financial leverage is moving towards 18x EBITDA following the recent preferred offering, and the participating rights could create a liability for the common holders that could grow over time and a common dividend AFFO payout ratio over 130% estimated through YE19. 5. Banco Santander (SAN) downgraded to Neutral from Buy at Goldman Sachs with analyst Jose Abad seeing the valuation as full following the recent outperformance of the shares. The analyst lowered his price target for the shares to EUR 6.40. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/17
08/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Overweight from Neutral at Cantor with analyst Kip Paulson saying he believes the risk/reward has shifted significantly following yesterday's expiration of the largest remaining lock-up period and the 8.5% share decline since Snap's second quarter earnings report. 2. GoPro (GPRO) upgraded to Neutral from Sell at Goldman Sachs with analyst Doug Clark saying GoPro is on track to launch a new HERO6 camera in the second half of 2017, and product launches have historically been a positive catalyst for the stock. 3. NetApp (NTAP) upgraded to Buy from Neutral at Longbow with analyst Joe Wittine citing a survey which showed that the company's share gains have continued. 4. American Eagle (AEO) upgraded to Buy from Neutral at FBR Capital with analyst Susan Anderson saying the valuation "has become very attractive." 5. Zynerba (ZYNE) upgraded to Buy from Neutral at Roth Capital with analyst Michael Higgins saying he was not bullish on yesterday's failed ZYN002 in osteoarthritis study. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WNRL Western Refining Logistics
$25.60

0.45 (1.79%)

08/16/17
MUFG
08/16/17
UPGRADE
Target $60
MUFG
Overweight
Andeavor Logistics upgraded to Overweight from Neutral at MUFG
MUFG analyst Barrett Blaschke upgraded Andeavor Logistics (ANDX) to Overweight with an unchanged price target of $60. The acquisition of Western Refining Logistics (WNRL) makes Andeavor a "stronger entity" with a wider base of assets, a "sustainable rate" of distribution growth and a lower-cost of capital which should support long-term growth, Blaschke tells investors in a research note.
01/11/17
WELS
01/11/17
DOWNGRADE
WELS
Market Perform
Western Refining Logistics downgraded to Market Perform at Wells Fargo
Wells Fargo analyst Michael Blum downgraded Western Refining Logistics to Market Perform from Outperform citing valuation. The analyst lowered his price target range for the shares to $22-$24 from $27-$29.
ANDX Andeavor Logistics
$49.04

0.7 (1.45%)

TODAY'S FREE FLY STORIES

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

16:26
02/24/18
02/24
16:26
02/24/18
16:26
Hot Stocks
Buffett believes Berkshire can handle $400B mega-catastrophe »

In his annual letter to…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

16:19
02/24/18
02/24
16:19
02/24/18
16:19
Periodicals
Buffet says laments inability to find targets for Berkshire to buy, Reuters says »

Warren Buffett lamented…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

16:16
02/24/18
02/24
16:16
02/24/18
16:16
Periodicals
Berkshire Hathaway reports record profit fueled by tax reform, Reuters says »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$32.66

0.55 (1.71%)

16:12
02/24/18
02/24
16:12
02/24/18
16:12
Periodicals
Twitter's SoundCloud investment officially wiped out, Recode reports »

Twitter has written off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

AAPL

Apple

$175.50

3 (1.74%)

16:08
02/24/18
02/24
16:08
02/24/18
16:08
Periodicals
Apple to store sensitive encryption keys in China, WSJ reports »

Apple will start to store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$40.98

0.09 (0.22%)

16:00
02/24/18
02/24
16:00
02/24/18
16:00
Periodicals
Volkswagen's U.S. unit settles emissions suit, Reuters reports »

Volkswagen's unit in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.46

0.91 (1.73%)

, UAL

United Continental

$67.57

0.87 (1.30%)

15:56
02/24/18
02/24
15:56
02/24/18
15:56
Periodicals
Delta, United Airlines cut ties with NRA, Reuters reports »

Delta Air Lines (DAL) and…

DAL

Delta Air Lines

$53.46

0.91 (1.73%)

UAL

United Continental

$67.57

0.87 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 30

    May

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

15:53
02/24/18
02/24
15:53
02/24/18
15:53
Earnings
Berkshire Hathaway reports Q4 operating EPS $3,338, consensus $2,622.23 »

Reports FY17 operating…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$94.70

0.33 (0.35%)

, T

AT&T

$36.72

0.25 (0.69%)

15:44
02/24/18
02/24
15:44
02/24/18
15:44
Periodicals
May be time to consider Time Warner, Barron's says »

Time Warner (TWX) shares…

TWX

Time Warner

$94.70

0.33 (0.35%)

T

AT&T

$36.72

0.25 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 23

    Apr

JKHY

Jack Henry

$121.95

1.79 (1.49%)

12:59
02/24/18
02/24
12:59
02/24/18
12:59
Conference/Events
Jack Henry management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

PFBC

Preferred Bank

$64.05

0.86 (1.36%)

12:52
02/24/18
02/24
12:52
02/24/18
12:52
Conference/Events
Preferred Bank management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 13

    Mar

  • 24

    Sep

R

Ryder

$74.54

0.19 (0.26%)

12:47
02/24/18
02/24
12:47
02/24/18
12:47
Conference/Events
Ryder management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

ASPU

Aspen Group

$8.85

1.48 (20.08%)

12:29
02/24/18
02/24
12:29
02/24/18
12:29
Conference/Events
Aspen Group to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

TWTR

Twitter

$32.66

0.55 (1.71%)

, AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

10:47
02/24/18
02/24
10:47
02/24/18
10:47
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWTR

Twitter

$32.66

0.55 (1.71%)

AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

RGR

Sturm, Ruger

$49.90

0.9 (1.84%)

X

U.S. Steel

$43.52

0.54 (1.26%)

STLD

Steel Dynamics

$47.47

-0.53 (-1.10%)

NUE

Nucor

$66.94

-0.01 (-0.01%)

AKS

AK Steel

$5.50

-0.12 (-2.14%)

AET

Aetna

$175.55

0.49 (0.28%)

ANTM

Anthem

$235.24

1.56 (0.67%)

CNC

Centene

$100.45

0.96 (0.96%)

CI

Cigna

$194.79

2.89 (1.51%)

HNT

Health Net

HUM

Humana

$271.19

3.38 (1.26%)

MOH

Molina Healthcare

$72.94

1.38 (1.93%)

UNH

UnitedHealth

$230.16

3.07 (1.35%)

WCG

WellCare

$192.05

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 07

    Mar

  • 13

    Mar

  • 16

    Apr

  • 30

    May

DBX

Dropbox

, SNAP

Snap

$17.45

-0.06 (-0.34%)

09:49
02/24/18
02/24
09:49
02/24/18
09:49
Periodicals
Dropbox IPO bodes well, Barron's says »

In a follow-up article…

DBX

Dropbox

SNAP

Snap

$17.45

-0.06 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

IPG

Interpublic Group

$24.24

0.3 (1.25%)

, OMC

Omnicom

$77.31

0.52 (0.68%)

09:42
02/24/18
02/24
09:42
02/24/18
09:42
Periodicals
Advertising companies cheaper than usual, Barron's says »

After a tumble last year,…

IPG

Interpublic Group

$24.24

0.3 (1.25%)

OMC

Omnicom

$77.31

0.52 (0.68%)

PUBGY

Publicis

$18.82

0.09 (0.48%)

WPP

WPP

$95.30

0.93 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 05

    Mar

MSFT

Microsoft

$94.06

2.33 (2.54%)

, INTC

Intel

$47.73

1.93 (4.21%)

09:36
02/24/18
02/24
09:36
02/24/18
09:36
Periodicals
Quantum computing soon to be reality, Barron's says »

Microsoft (MSFT) predicts…

MSFT

Microsoft

$94.06

2.33 (2.54%)

INTC

Intel

$47.73

1.93 (4.21%)

NVDA

Nvidia

$245.93

3.78 (1.56%)

MU

Micron

$46.53

2.28 (5.15%)

GOOG

Alphabet

$1,126.79

20.16 (1.82%)

GOOGL

Alphabet Class A

$1,128.09

18.19 (1.64%)

AMZN

Amazon.com

$1,500.00

14.66 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

AMZN

Amazon.com

$1,500.00

14.66 (0.99%)

09:26
02/24/18
02/24
09:26
02/24/18
09:26
Periodicals
Many downsides when Amazon's HQ2 comes to town, Barron's says »

As Amazon decides on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

BHGE

Baker Hughes

$28.03

-0.01 (-0.04%)

04:55
02/24/18
02/24
04:55
02/24/18
04:55
Conference/Events
Baker Hughes management to meet with UBS »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

GE

General Electric

$14.49

-0.01 (-0.07%)

18:49
02/23/18
02/23
18:49
02/23/18
18:49
Periodicals
General Electric could face DOJ action over subprime mortgages, Reuters says »

General Electric may face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$20.15

0.34 (1.72%)

18:30
02/23/18
02/23
18:30
02/23/18
18:30
Syndicate
Bright Scholar files to sell 10M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

, CMD

Cantel Medical

$115.34

2.45 (2.17%)

18:03
02/23/18
02/23
18:03
02/23/18
18:03
Periodicals
J&J sterilization unit draws bids from Cantel Medical, Medtronic, Bloomberg says »

Cantel Medical (CMD) and…

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

CMD

Cantel Medical

$115.34

2.45 (2.17%)

MDT

Medtronic

$80.39

-0.02 (-0.02%)

KKR

KKR

$21.96

0.18 (0.83%)

CG

Carlyle Group

$23.15

-0.1 (-0.43%)

MMM

3M

$237.02

1.02 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 14

    Mar

  • 23

    Mar

  • 23

    Apr

  • 30

    May

AET

Aetna

$175.55

0.49 (0.28%)

, CVS

CVS Health

$68.16

0.16 (0.24%)

18:00
02/23/18
02/23
18:00
02/23/18
18:00
Hot Stocks
Aetna: CVS deal part of long-term solution toward value-based system »

According to prepared…

AET

Aetna

$175.55

0.49 (0.28%)

CVS

CVS Health

$68.16

0.16 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 30

    May

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:56
02/23/18
02/23
17:56
02/23/18
17:56
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:55
02/23/18
02/23
17:55
02/23/18
17:55
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.